Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials.
作者信息
Krishnan Jamuna K, Calverley Peter M A
机构信息
Division of Pulmonary and Critical Care Medicine Weill Cornell Medicine New York, New York.
Institute of Ageing and Chronic Disease University of Liverpool Liverpool, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2022 Aug 1;206(3):235-236. doi: 10.1164/rccm.202204-0688ED.
Abstract
摘要
相似文献
1
Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials.了解被排除在慢性阻塞性肺疾病临床试验之外的人群。
Am J Respir Crit Care Med. 2022 Aug 1;206(3):235-236. doi: 10.1164/rccm.202204-0688ED.
2
Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.慢性阻塞性肺疾病药物治疗：一项历史非干预性队列研究，与 RCT 结果相验证。
Health Technol Assess. 2021 Aug;25(51):1-70. doi: 10.3310/hta25510.
3
Effects of whole body vibration on pulmonary function, functional exercise capacity and quality of life in people with chronic obstructive pulmonary disease: a systematic review.全身振动对慢性阻塞性肺疾病患者肺功能、功能锻炼能力及生活质量的影响：一项系统评价
Clin Rehabil. 2016 May;30(5):419-31. doi: 10.1177/0269215515589202. Epub 2015 Jun 2.
4
Balance is impaired in people with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的平衡能力受损。
Gait Posture. 2010 Apr;31(4):456-60. doi: 10.1016/j.gaitpost.2010.01.022. Epub 2010 Mar 4.
5
A randomised controlled trial of supplemental oxygen versus medical air during exercise training in people with chronic obstructive pulmonary disease: supplemental oxygen in pulmonary rehabilitation trial (SuppORT) (Protocol).慢性阻塞性肺疾病患者运动训练期间补充氧气与医用空气的随机对照试验：肺康复试验中的补充氧气（SuppORT）（方案）
BMC Pulm Med. 2016 Feb 4;16:25. doi: 10.1186/s12890-016-0186-4.
6
7
Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?哮喘与慢性阻塞性肺疾病重叠：哮喘型慢性阻塞性肺疾病还是慢性阻塞性哮喘？
Ther Adv Respir Dis. 2016 Feb;10(1):57-71. doi: 10.1177/1753465815617082. Epub 2015 Nov 22.
8
Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: A cross-sectional study.慢性阻塞性肺疾病（COPD）合并间质性肺异常的日本患者的临床特征：一项横断面研究。
PLoS One. 2020 Nov 10;15(11):e0239764. doi: 10.1371/journal.pone.0239764. eCollection 2020.
9
[The study on the value of using the chronic obstructive pulmonary disease and asthma physiology score to assess the severity of acute exacerbation in patients with chronic obstructive pulmonary disease complicated by type II respiratory failure].[应用慢性阻塞性肺疾病与哮喘生理学评分评估慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者急性加重严重程度的价值研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 May;22(5):275-8.
10
[Treatment and prognosis of the severe exacerbation in the chronic obstructive pulmonary disease].[慢性阻塞性肺疾病严重加重期的治疗与预后]
Rev Clin Esp. 2001 Nov;201(11):658-66. doi: 10.1016/s0014-2565(01)70941-1.
引用本文的文献
1
Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study.慢性阻塞性肺疾病单吸入器三联疗法的比较有效性和安全性：新用户队列研究
BMJ. 2024 Dec 30;387:e080409. doi: 10.1136/bmj-2024-080409.
2
Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET.三联疗法对 GOLD 分组 C 和 D 患者疾病负担的影响：COSYCONET 观察性 COPD 队列研究结果。
BMC Pulm Med. 2024 Mar 1;24(1):103. doi: 10.1186/s12890-024-02902-4.
本文引用的文献
1
Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials.不符合主要临床试验条件的慢性阻塞性肺疾病患者的预后。
Am J Respir Crit Care Med. 2022 Aug 1;206(3):271-280. doi: 10.1164/rccm.202110-2441OC.
2
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.慢性阻塞性肺疾病和慢性阻塞性肺疾病前患者的青年患者治疗试验：是时候向前推进了。
Am J Respir Crit Care Med. 2022 Feb 1;205(3):275-287. doi: 10.1164/rccm.202107-1663SO.
3
Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement.提高肺脏、危重症和睡眠医学临床研究中少数民族人群的招募和保留率：美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2021 Aug 1;204(3):e26-e50. doi: 10.1164/rccm.202105-1210ST.
4
ACO (Asthma-COPD Overlap) Is Independent from COPD: The Case in Favour.哮喘-慢性阻塞性肺疾病重叠综合征（ACO）独立于慢性阻塞性肺疾病（COPD）：支持这一观点的案例
Diagnostics (Basel). 2021 Jun 30;11(7):1189. doi: 10.3390/diagnostics11071189.
5
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
6
Update on Clinical Aspects of COPD. Reply.慢性阻塞性肺疾病临床进展。回复。
N Engl J Med. 2019 Dec 19;381(25):2485-2486. doi: 10.1056/NEJMc1914600.
7
Diagnosis and management of asthma, COPD and asthma-COPD overlap among primary care physicians and respiratory/allergy specialists: A global survey.基层医疗医生与呼吸科/过敏科专家对哮喘、慢性阻塞性肺疾病及哮喘-慢性阻塞性肺疾病重叠综合征的诊断与管理：一项全球调查。
Clin Respir J. 2019 Jun;13(6):355-367. doi: 10.1111/crj.13016. Epub 2019 Mar 24.
8
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.慢性阻塞性肺疾病（COPD）真实世界患者纳入吸入长效支气管扩张剂治疗试验的资格。
Respir Res. 2016 Sep 23;17(1):120. doi: 10.1186/s12931-016-0433-5.
9
Large trials, new knowledge: the changing face of COPD management.大型试验，新知涌现：慢阻肺管理的面貌正在改变。
Eur Respir J. 2015 Jun;45(6):1692-703. doi: 10.1183/09031936.00179714. Epub 2015 Mar 18.
10
Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.重叠表型（COPD-哮喘）患者的加重和住院风险增加。
Chest. 2014 Feb;145(2):297-304. doi: 10.1378/chest.13-0622.
Zotero 插件